XUND

XUND

Private
ViennaHealthcare & Life Scienceshttps://xund.ai/

Last Round

Early Funding

Mar 5, 2025

Total Funding Raised

$15.35M

Momentum Score

25 /100

Company Overview

XUND is a healthtech company that develops an AI-powered technology designed to digitize the patient journey, guiding patients from prevention to diagnosis.

Sector

Healthcare & Life Sciences

Verticals

Patient Engagement, Medical AI, Vertical SaaS, NLP & Conversational AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

AI symptom checkerSoftware as a Medical DeviceSaMDhealthcare APIdigital triagepatient navigationdigital front doormedical AIClass IIa medical deviceMDR certificationpatient engagement platformAI health assistantclinical decision supportmedical chatbotmedical NLPhealth risk assessmentB2B2C healthcare

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

XUND Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

XUND Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Early FundingMar 5, 2025
SeedApr 2, 2024
SeedOct 3, 2022
AngelMar 10, 2020

Key People

Founding team and executive leadership

Lukas Seper

Co-Founder Chief Revenue Officer

Founding Team

Tamás Petrovics

Co-Founder CEO

Founding Team

Krisztián Monostori

Chief Technology Officer

Executive Team

Rafael Bisztyga

COO

Executive Team

XUND Investors

Notable investors and investment history

InvestorRounds
Peak PrideSeed, Angel
Lead VenturesEarly Funding
RoX HealthSeed
MassMutual VenturesSeed, Early Funding
J&T VenturesEarly Funding
MMC VenturesSeed
2m-quadrat AGSeed

XUND Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

XUND Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about XUND's valuation, stock price, and market status.

Firmographic Details

HeadquartersVienna
Employee Range69
Year Founded2018
Last FundingMar 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.